Ventyx Biosciences announces seven additional appointments to SAB

Ventyx Biosciences (VTYX) announced the appointment of seven additional internationally-recognized scientists and clinicians to its Scientific Advisory Board, SAB: Mo Lamkanfi, PhD, Luke O’Neill, PhD, Ted Dawson, MD, PhD, Martin Pomper, MD, PhD, Antonio Abbate, MD, PhD, Paul Cremer, MD and Don Frail, PhD. The new SAB members have made vital discoveries in understanding the role of the NLRP3 inflammasome in neuro- and systemic inflammation, and are at the forefront of clinical development in neurodegenerative and cardiometabolic diseases. The seven new members join Ventyx’s existing SAB members who are leading immunology experts in inflammatory bowel disease and dermal diseases.